ArticleWorld journal of urology2025

Clinical and urodynamic benefit of adding antimuscarinics after a loss of efficacy of intradetrusor botulinum toxin in patients with multiple sclerosis.

Adrien Haegel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.